(Q41539788)

English

Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma

scientific article published on August 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 October 2017

Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma (English)

1 reference

Europe PubMed Central

2 October 2017

author name string

L G LeMay

1

1 reference

Europe PubMed Central

2 October 2017

J Kan-Mitchell

2

1 reference

Europe PubMed Central

2 October 2017

P Goedegebuure

3

1 reference

Europe PubMed Central

2 October 2017

W Harel

4

1 reference

Europe PubMed Central

2 October 2017

M S Mitchell

5

1 reference

Europe PubMed Central

2 October 2017

publication date

1 August 1993

1 reference

Europe PubMed Central

2 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

2 October 2017

37

1 reference

Europe PubMed Central

2 October 2017

187-194

1 reference

Europe PubMed Central

2 October 2017

3

1 reference

Europe PubMed Central

2 October 2017

https://scigraph.springernature.com/pub.10.1007/bf01525434

0 references

Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active-specific immunotherapy for melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon-gamma increases HLA-DR synthesis and expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of self peptides bound to purified HLA-B27

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of CD4 in T-cell activation: accessory molecule or co-receptor?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation antigens of melanoma and melanocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attempts to Optimize Active Specific Immunotherapy for Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A model for T cell receptor and MHC/peptide interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hapten-specific, class II-restricted killing by cloned T cells: direct lysis and production of a cytotoxic factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human autologous tumor-specific T cells in malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second proteasome-related gene in the human MHC class II region

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perturbation of the T4 molecule transmits a negative signal to T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8101473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01525434

1 reference

Europe PubMed Central

2 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41539788&oldid=1924121525"